All AIDS 2024 articles

  • Low-Res_First PrEPVacc volunteer receives his injections and medicines at the launch of the launch of the PrePVacc Trial at the Masaka site
    News

    HIV vaccines tested in PrEPVacc fail to reduce infections

    2024-07-23T14:13:00Z

    The results of the PrEPVacc HIV vaccine trial conducted in Eastern and Southern Africa, which ran between 2020 and 2024, show that neither of the two experimental vaccine regimens tested reduced HIV infections among the study population.